Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J B Robbins

Showing results (171-180 of 223) with videos related to

Pageof 23
Sort By:
Infection and Immunity|November 14, 1997
Detoxified lipooligosaccharide from nontypeable Haemophilus influenzae conjugated to proteins confers protection against otitis media in chinchillasX X Gu, J Sun, S Jin, et al.
Infection and Immunity|November 1, 1972
Enteric bacteria cross-reactive with Neisseria meningitidis groups A and C and Diplococcus pneumoniae types I and 3J B Robbins, L Myerowitz, J K Whisnant, et al.
Infection and Immunity|February 1, 1992
Comparative immunogenicity of conjugates composed of the Staphylococcus aureus type 8 capsular polysaccharide bound to carrier proteins by adipic acid dihydrazide or N-succinimidyl-3-(2-pyridyldithio)propionateA Fattom, J Shiloach, D Bryla, et al.
The Pediatric Infectious Disease Journal|August 1, 1991
Persistence of serum antibodies elicited by Haemophilus influenzae type b-tetanus toxoid conjugate vaccine in infants vaccinated at 3, 5 and 12 months of ageB A Claesson, R Schneerson, T Lagergård, et al.
Progress in Clinical and Biological Research|January 1, 1979
Studies on Limulus lysate coagulating systemT Y Liu, R C Seid, J Y Tai, et al.
The Pediatric Infectious Disease Journal|February 1, 1997
Unchanged efficacy of a pertussis toxoid vaccine throughout the two years after the third vaccination of infantsJ Taranger, B Trollfors, T Lagergård, et al.
Infection and Immunity|March 18, 2000
Clostridium difficile recombinant toxin A repeating units as a carrier protein for conjugate vaccines: studies of pneumococcal type 14, Escherichia coli K1, and Shigella flexneri type 2a polysaccharides in miceD Pavliakova, J S Moncrief, D M Lyerly, et al.
Biochemistry|August 9, 1977
Structural studies on the sialic acid polysaccharide antigen of Escherichia coli strain Bos-12W Egan, T Y Liu, D Dorow, et al.
Lancet (London, England)|May 17, 1975
Epidemiology of Escherichia coli K1 in healthy and diseased newbornsL D Sarff, G H McCracken, M S Schiffer, et al.
The Journal of Infectious Diseases|August 1, 1977
Neonatal meningitis due of Escherichia coli K1M P Glode, A Sutton, J B Robbins, et al.
Pageof 23

Showing results (171-180 of 223) with videos related to

Sort By:
Pageof 23
Infection and Immunity|November 14, 1997
Detoxified lipooligosaccharide from nontypeable Haemophilus influenzae conjugated to proteins confers protection against otitis media in chinchillasX X Gu, J Sun, S Jin, et al.
Infection and Immunity|November 1, 1972
Enteric bacteria cross-reactive with Neisseria meningitidis groups A and C and Diplococcus pneumoniae types I and 3J B Robbins, L Myerowitz, J K Whisnant, et al.
Infection and Immunity|February 1, 1992
Comparative immunogenicity of conjugates composed of the Staphylococcus aureus type 8 capsular polysaccharide bound to carrier proteins by adipic acid dihydrazide or N-succinimidyl-3-(2-pyridyldithio)propionateA Fattom, J Shiloach, D Bryla, et al.
The Pediatric Infectious Disease Journal|August 1, 1991
Persistence of serum antibodies elicited by Haemophilus influenzae type b-tetanus toxoid conjugate vaccine in infants vaccinated at 3, 5 and 12 months of ageB A Claesson, R Schneerson, T Lagergård, et al.
Progress in Clinical and Biological Research|January 1, 1979
Studies on Limulus lysate coagulating systemT Y Liu, R C Seid, J Y Tai, et al.
The Pediatric Infectious Disease Journal|February 1, 1997
Unchanged efficacy of a pertussis toxoid vaccine throughout the two years after the third vaccination of infantsJ Taranger, B Trollfors, T Lagergård, et al.
Infection and Immunity|March 18, 2000
Clostridium difficile recombinant toxin A repeating units as a carrier protein for conjugate vaccines: studies of pneumococcal type 14, Escherichia coli K1, and Shigella flexneri type 2a polysaccharides in miceD Pavliakova, J S Moncrief, D M Lyerly, et al.
Biochemistry|August 9, 1977
Structural studies on the sialic acid polysaccharide antigen of Escherichia coli strain Bos-12W Egan, T Y Liu, D Dorow, et al.
Lancet (London, England)|May 17, 1975
Epidemiology of Escherichia coli K1 in healthy and diseased newbornsL D Sarff, G H McCracken, M S Schiffer, et al.
The Journal of Infectious Diseases|August 1, 1977
Neonatal meningitis due of Escherichia coli K1M P Glode, A Sutton, J B Robbins, et al.
Pageof 23